[Mechanism of arsenic compound resistance in prokaryotes and eukaryotes].
Wysocki
R
R
Zakład Genetyki, Instytut Mikrobiologii, Uniwersytet Wrocławski, Wrocław.
Bobrowicz
P
P
Ułaszewski
S
S
D000818:Animals; D001152:Arsenicals / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000187:drug effects / Q000235:genetics; D004351:Drug Resistance; D056890:Eukaryota / Q000187:drug effects; D005057:Eukaryotic Cells / Q000187:drug effects* / Q000469:parasitology; D007942:Leukemia, Experimental / Q000188:drug therapy; D009876:Operon / Q000187:drug effects / Q000502:physiology; D011387:Prokaryotic Cells / Q000187:drug effects*; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D029701:Saccharomyces cerevisiae Proteins; D029702:Schizosaccharomyces pombe Proteins; D014157:Transcription Factors
C061886:ABF1 protein, S cerevisiae; D001152:Arsenicals; D004268:DNA-Binding Proteins; D029701:Saccharomyces cerevisiae Proteins; D029702:Schizosaccharomyces pombe Proteins; D014157:Transcription Factors; C097691:cbp1 protein, S pombe